Broach Lifecare Hospital Limited

Broach Lifecare Hospital Limited

BBSE:BROACH
14.00
INR
-1.00
(-6.67%)
105.56MMarket Cap
2021 Y
2022 Y
2023 Y
2024 Y
2025 Y
2026 Y
TTM
Revenue per Share
6.04
5.59
2.99
4.29
5.81
9.88
- -
Basic EPS, GAAP
1.26
0.76
0.23
1.15
0.98
0.14
- -
Free Cash Flow per Basic Share
-0.07
-2.9
-4.67
-7.74
-1.87
-3.26
- -
Dividend per Share
- -
- -
- -
- -
- -
- -
- -
Book Value per Share
3.16
3.71
3.56
9.01
15.43
15.57
15.57
Tangible Book Value per Share
3.16
3.71
3.56
9.01
15.43
15.57
15.57
Basic Weighted Avg Shares
6
6
6
6
5
6
6
Sales/Revenue/Turnover
37
34
18
26
32
60
- -
Operating Margin (%)
28.21
27.84
19.72
36.48
22.59
3.85
- -
Depreciation Expense
2
3
4
1
1
3
- -
Net Income, GAAP
8
5
1
7
5
1
- -
Effective Tax Rate (%)
26
26
26.01
25.26
25.16
58.75
- -
Profit Margin (%)
20.89
13.54
7.63
26.77
16.85
1.45
- -
Working Capital
-3
-6
3
11
15
24
24
LT Debt
7
25
57
- -
- -
- -
- -
Total Equity
19
23
22
55
94
95
95
Return on Invested Capital (%)
- -
12.39
3.97
10.14
6.43
0.87
- -
Return on Capital (%)
- -
14.05
4.96
10.29
6.99
1.02
- -
Return on Common Equity (%)
- -
22.03
6.27
18.28
7.23
0.92
- -

Capital Structure

INR

•

in mil. unless spec.
Mar'25
Sep'26
Mar'26
ST Debt
10
- -
- -
LT Borrowings
- -
- -
- -
LT Finance Leases
- -
- -
- -
Preferred Equity and Hybrid Capital
- -
- -
- -
Shares Outstanding
6
6
6
Market Capitalization
100
118
106

Working Capital

INR

•

in mil. unless spec.
Mar'25
Sep'26
Mar'26
Total Current Assets
30
66
35
Cash, Cash Equivalents & STI
2
7
3
Accounts Receivable, Net
6
8
9
Inventories
4
7
4
Total Current Liabilities
15
9
11
Payables & Accruals
- -
- -
- -
ST Debt
10
- -
- -
Deferred Revenue
- -
- -
- -

Growth Rates

INR

•

in mil. unless spec.

(avg. rate of change)

10 years
5 years
1 year
Total Equity
- -
47.72%
0.93%
Free Cash Flow
- -
883.19%
93.48%
Net Income, GAAP
- -
37.37%
-83.8%
Sales/Revenue/Turnover
- -
20.04%
88.55%
Total Cash Common Dividend
- -
- -
- -

Semi-annual Revenue

INR

•

in mil. unless spec.

Year

H1
H2
FY
2024
- -
- -
26
2025
- -
- -
32
2026
- -
- -
60

Semi-annual Earnings Per Share

INR

•

in mil. unless spec.

Year

H1
H2
FY
2024
- -
- -
1.15
2025
- -
- -
0.98
2026
- -
- -
0.14

Semi-annual Dividends Per Share

INR

•

in mil. unless spec.

Year

H1
H2
FY
2024
- -
- -
- -
2025
- -
- -
- -
2026
- -
- -
- -

Company Description

Sector
Health services
Industry
Hospital/Nursing management
Address
Bharuch India
IPO Date
Aug 21, 2024
Business
Broach Lifecare Hospital Limited is a healthcare services provider that owns and operates boutique multi-specialty hospitals under the brand name Maple Hospitals, specializing in comprehensive cardiac care, critical care, and emergency medical services. The company offers a wide spectrum of diagnostic, interventional, and therapeutic clinical solutions, structured across primary healthcare divisions: non-invasive cardiology diagnostics, including 2D echocardiography, electrocardiography (ECG), computerized treadmill testing (TMT), 24-hour Holter monitoring, ambulatory blood pressure monitoring, and dobutamine stress echocardiography; interventional cardiology and surgical procedures, including coronary angiography, percutaneous coronary intervention (PCI), primary angioplasty in myocardial infarction (PAMI), coronary stenting, temporary and permanent pacemaker implantation, intra-aortic balloon pump (IABP) therapy, and congenital heart defect interventions; critical and intensive cardiac care, featuring 24/7 cardiac emergency management, advanced intensive cardiac care units (ICCU), and mechanical ventilator support; and general multi-specialty services, covering outpatient consultations, inpatient hospitalization, pathological testing, digital radiography, and in-house pharmacy operations. Headquartered in Bharuch, Gujarat, India, the company was incorporated in 2023 to consolidate and expand healthcare operations previously managed under promoter proprietorships, primarily serving patients across the industrial districts of Bharuch and Ankleshwar in Gujarat. In recent developments, Broach Lifecare Hospital Limited completed its initial public offering (IPO) and listed on the BSE SME platform in August 2024, utilizing the net proceeds to fund capital expenditures for advanced medical machinery, scale its catheterization laboratory infrastructure, and establish a specialized medical tourism digital portal to expand its patient outreach.